Echocardiographic assessment of COVID19 sequelae in survivors with elevated cardiac biomarkers

Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19—Why Should Screening for Cardiovascular Diseases Be Performed? Reply to Vankrunkelsven, P. Tendentious Paper—Titles and Wrong Conclusions Lead to Fear in the Population and Medical Overconsumption. Comment on “Luchian et al. Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19. Diagnostics 2022, 12, 57”

“…Hereby, it is important to emphasize that all the patients have had COVID-19, in contrast to the reference values derived from the healthy study subjects of the NORRE study [ 5 ]. Our results are further supported by recent data showing the presence of endothelial dysfunction and persistent oxidative burden in symptomatic discharged COVID-19 patients linked to a mildly compromised cardiac performance, indicated by the values of myocardial work parameters and left ventricle global longitudinal strain [ 6 , 7 ]. The echocardiographic parameters at t 12-month follow-up reported by Ikonomidis et al, similar to our results, remained within the “normal range”; however, they were significantly different when compared to healthy individuals [ 6 ].…”

Beyond Acute COVID-19: A Review of Long-term Cardiovascular Outcomes

“…For example, Ródenas-Alesina and colleagues investigated myocardial infarction and mortality outcomes in COVID-19 patients with no previous cardiovascular disease at 7 months post hospitalization. 24 The authors found no difference in outcomes between those who were initially admitted with elevated high-sensitivity Troponin (hs-TnI >45 ng/L) compared to those without.…”

“… 22 Other studies have found no evidence of pericardial effusion in any participants during follow-up for acute COVID-19 illness. 23 , 24 …”

A Review of Long COVID With a Special Focus on Its Cardiovascular Manifestations

“…Follow-up of patients with elevated CVB during acute infection showed that a subgroup still had persistently elevated CVB at five months. These were associated with alterations in ventricular function on echocardiography [ 38 ].…”